Staff Writer


Early Data Suggest Promise for Immunotherapies in Lymphomas

October 13, 2015

Questions persist regarding mechanisms of PD-L1 overexpression in lymphoid malignancies, patient selection, biomarkers to guide therapy and predict response, and identification of agents to use in combination with PD-1/PD-L1 inhibitors.

Molecular Subtype Proves to Be Prognostic Factor in Newly Diagnosed Gliomas

September 16, 2015

This reanalysis confirmed that there is no difference for a radiotherapy-first versus a chemotherapy-first strategy in this setting, but there is a major difference in long-term outcomes for molecular stratification independent of treatment.